+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Sale

Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083757
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cryptococcosis market is undergoing rapid transformation, with shifting diagnostic and therapeutic approaches driving complexity and opportunity for informed leaders. Advanced innovation, evolving regulatory frameworks, and emerging risks require a nuanced understanding of the market’s segmented landscape and growth pathways.

Market Snapshot: Cryptococcosis Market Size and Growth

The Cryptococcosis Market grew from USD 6.35 billion in 2024 to USD 6.87 billion in 2025. It is expected to continue growing at a CAGR of 7.68%, reaching USD 9.91 billion by 2030. This momentum reflects increased disease awareness, ongoing therapeutic innovations, and the rising focus on early intervention. Expanding market adoption is evident across both developed and emerging economies, strengthened by updated clinical practices and evolving reimbursement models.

Scope & Segmentation of the Cryptococcosis Market

This report delivers a detailed segmentation and analysis of the following market components:

  • Drug Class: Azoles (including fluconazole, isavuconazole, itraconazole, posaconazole, voriconazole), echinocandins (anidulafungin, caspofungin, micafungin), polyenes, pyrimidine analogues
  • Indication: Cryptococcal meningitis, disseminated cryptococcosis, pulmonary cryptococcosis
  • Route of Administration: Intravenous, oral
  • End User: Ambulatory care centers, clinics, hospitals
  • Distribution Channel: Hospital, online, and retail pharmacies
  • Patient Type: HIV-positive, transplant patients
  • Regions: Americas (United States—including state-level details—Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Profiled: Gilead Sciences, Viatris, Teva, Novartis, Pfizer, Bausch Health, F. Hoffmann-La Roche, Merck, Bristol-Myers Squibb, Johnson & Johnson

Key technologies include rapid molecular diagnostics, cloud-based patient management, and enhanced drug delivery platforms, all integrated to address treatment efficacy and patient adherence.

Key Takeaways for Senior Decision-Makers

  • Treatment paradigms are swiftly evolving, with next-generation diagnostic tools enabling timely and precise detection of cryptococcosis pathogens, improving care delivery for at-risk populations.
  • Emerging drug formulations, such as extended-release azoles and novel echinocandins, are expanding therapeutic choices while offering improved safety and pharmacokinetic profiles over traditional options.
  • Strategic collaborations between drug developers and diagnostic companies are streamlining clinical workflows and reinforcing holistic care models, enhancing both supply chain resilience and patient outcomes.
  • Supply chain vulnerabilities have prompted a shift toward domestic manufacturing and supplier diversification, addressing regulatory and tariff-related uncertainties which can impact cost efficiency and continuity of care.
  • Regional variation in healthcare infrastructure and reimbursement approaches is shaping competitive dynamics, with tailored strategies necessary to capture growth and ensure broad patient access.
  • Lifecycle management, patient support programs, and regulatory agility will remain essential for sustaining competitive differentiation and value generation as the market matures.

Tariff Impact: United States 2025 Policy Changes

Recent tariff changes in the United States are increasing production costs for imported active pharmaceutical ingredients and finished cryptococcosis therapies. This regulatory landscape is prompting manufacturers to reassess supply chain strategies, including expanding domestic production and renegotiating contract terms. Proactive adaptation to tariff-related pressures is critical for maintaining stable access and cost-effective distribution, particularly for vulnerable patient groups reliant on consistent therapy.

Methodology & Data Sources

This report applies a rigorous research methodology, combining peer-reviewed literature, public health data, regulatory filings, and expert interviews. Quantitative and qualitative market data are triangulated and validated through multi-layered review, ensuring insights reflect current market realities and stakeholder priorities.

Cryptococcosis Market: Why This Report Matters

  • Provides actionable, segment-specific intelligence designed to inform strategic planning, market positioning, and product development.
  • Enables leaders to anticipate regulatory, supply chain, and competitive shifts, supporting risk mitigation and resource optimization.
  • Empowers teams to prioritize investments and foster collaborations tailored to maximize growth opportunities and improve patient care.

Conclusion

The cryptococcosis market is defined by constant evolution and multifaceted challenges, demanding agile strategies and integrated, data-driven decision-making. Business leaders equipped with deep, segmented insights will be best positioned to drive value, advance patient outcomes, and lead in a highly dynamic competitive environment.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cryptococcosis Market, by Drug Class
8.1. Introduction
8.2. Azoles
8.2.1. Fluconazole
8.2.2. Isavuconazole
8.2.3. Itraconazole
8.2.4. Posaconazole
8.2.5. Voriconazole
8.3. Echinocandins
8.3.1. Anidulafungin
8.3.2. Caspofungin
8.3.3. Micafungin
8.4. Polyenes
8.5. Pyrimidine Analogues
9. Cryptococcosis Market, by Indication
9.1. Introduction
9.2. Cryptococcal Meningitis
9.3. Disseminated Cryptococcosis
9.4. Pulmonary Cryptococcosis
10. Cryptococcosis Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Cryptococcosis Market, by End User
11.1. Introduction
11.2. Ambulatory Care Center
11.3. Clinic
11.4. Hospital
12. Cryptococcosis Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Cryptococcosis Market, by Patient Type
13.1. Introduction
13.2. Hiv Positive
13.3. Transplant Patients
14. Americas Cryptococcosis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cryptococcosis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cryptococcosis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Gilead Sciences, Inc.
17.3.2. Viatris Inc.
17.3.3. Teva Pharmaceutical Industries Ltd.
17.3.4. Novartis AG
17.3.5. Pfizer Inc.
17.3.6. Bausch Health Companies Inc.
17.3.7. F. Hoffmann-La Roche Ltd.
17.3.8. Merck & Co., Inc.
17.3.9. Bristol-Myers Squibb Company
17.3.10. Johnson & Johnson
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CRYPTOCOCCOSIS MARKET MULTI-CURRENCY
FIGURE 2. CRYPTOCOCCOSIS MARKET MULTI-LANGUAGE
FIGURE 3. CRYPTOCOCCOSIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CRYPTOCOCCOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CRYPTOCOCCOSIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CRYPTOCOCCOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ISAVUCONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POSACONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY VORICONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY MICAFUNGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POLYENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PYRIMIDINE ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CRYPTOCOCCAL MENINGITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISSEMINATED CRYPTOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PULMONARY CRYPTOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HIV POSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY TRANSPLANT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 58. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 59. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 60. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 131. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 132. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 133. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 187. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 188. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 189. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 250. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 251. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 252. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 253. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 276. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 277. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 278. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 284. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 285. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 286. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 327. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 354. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 361. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 362. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN CRYPTOCOCCOSIS MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cryptococcosis market report include:
  • Gilead Sciences, Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Bausch Health Companies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.87 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.91 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cryptococcosis Market Report 2025 - Product Image

Cryptococcosis Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cryptococcosis Treatment Market by Drug Class, End User, Administration Route, Distribution Channel, Patient Type - Global Forecast to 2030 - Product Image

Cryptococcosis Treatment Market by Drug Class, End User, Administration Route, Distribution Channel, Patient Type - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cryptococcosis Therapeutics - Global Strategic Business Report - Product Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From

About the Cryptococcosis Drug Market

Cryptococcosis is a fungal infection caused by the Cryptococcus neoformans and Cryptococcus gattii species. It is a serious infection that can affect the lungs, central nervous system, and other organs. Treatment of cryptococcosis typically involves antifungal medications, such as amphotericin B, fluconazole, and voriconazole. These drugs are used to treat both cryptococcal meningitis and cryptococcal pneumonia. The cryptococcosis drug market is a subset of the infectious diseases drug market. It is composed of antifungal medications used to treat cryptococcosis. These drugs are used to treat both cryptococcal meningitis and cryptococcal pneumonia. Some companies in the cryptococcosis drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.